Annual Total Long Term Liabilities
$6.27 M
-$8.65 M-57.97%
December 31, 2023
Summary
- As of February 7, 2025, ALDX annual total long term liabilities is $6.27 million, with the most recent change of -$8.65 million (-57.97%) on December 31, 2023.
- During the last 3 years, ALDX annual total long term liabilities has fallen by -$5.16 million (-45.15%).
- ALDX annual total long term liabilities is now -76.57% below its all-time high of $26.77 million, reached on December 31, 2012.
Performance
ALDX Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Liabilities
$15.07 M
+$14.93 M+10749.68%
September 30, 2024
Summary
- As of February 7, 2025, ALDX quarterly total long term liabilities is $15.07 million, with the most recent change of +$14.93 million (+10749.68%) on September 30, 2024.
- Over the past year, ALDX quarterly long term liabilities has increased by +$12.41 million (+467.15%).
- ALDX quarterly long term liabilities is now -43.70% below its all-time high of $26.77 million, reached on December 31, 2012.
Performance
ALDX Quarterly Long Term Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Liabilities Formula
Long-Term Liabilities = Long-Term Debt + Deferred Tax Liabilities + Pension Liabilities + Other Long-Term Liabilities
ALDX Long Term Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -58.0% | +467.1% |
| 3 y3 years | -45.1% | -3.4% |
| 5 y5 years | +100.0% | +4.3% |
ALDX Long Term Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -59.9% | at low | -3.7% | >+9999.0% |
| 5 y | 5-year | -59.9% | at low | -3.7% | >+9999.0% |
| alltime | all time | -76.6% | -100.0% | -43.7% | -100.0% |
Aldeyra Therapeutics Long Term Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $15.07 M(>+9900.0%) |
| Jun 2024 | - | $138.90 K(-97.8%) |
| Mar 2024 | - | $6.21 M(-1.0%) |
| Dec 2023 | $6.27 M(-58.0%) | $6.27 M(+136.0%) |
| Sep 2023 | - | $2.66 M(-73.8%) |
| Jun 2023 | - | $10.13 M(-32.3%) |
| Mar 2023 | - | $14.97 M(+0.3%) |
| Dec 2022 | $14.92 M(-4.5%) | $14.92 M(+351.8%) |
| Sep 2022 | - | $3.30 M(-69.3%) |
| Jun 2022 | - | $10.74 M(-31.4%) |
| Mar 2022 | - | $15.65 M(+0.1%) |
| Dec 2021 | $15.63 M(+36.7%) | $15.63 M(+0.1%) |
| Sep 2021 | - | $15.61 M(+1.7%) |
| Jun 2021 | - | $15.34 M(+51.3%) |
| Mar 2021 | - | $10.14 M(-11.3%) |
| Dec 2020 | $11.43 M(-21.3%) | $11.43 M(-9.9%) |
| Sep 2020 | - | $12.69 M(-8.8%) |
| Jun 2020 | - | $13.92 M(-5.1%) |
| Mar 2020 | - | $14.67 M(+1.0%) |
| Dec 2019 | $14.53 M(>+9900.0%) | $14.53 M(+0.6%) |
| Sep 2019 | - | $14.45 M(>+9900.0%) |
| Jun 2019 | - | $116.10 K(-26.0%) |
| Mar 2019 | - | $156.80 K(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2018 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sep 2018 | - | $882.80 K(-11.3%) |
| Jun 2018 | - | $995.30 K(-10.1%) |
| Mar 2018 | - | $1.11 M(-9.2%) |
| Dec 2017 | $1.22 M(-1.5%) | $1.22 M(+34.8%) |
| Sep 2017 | - | $905.30 K(-10.9%) |
| Jun 2017 | - | $1.02 M(-9.9%) |
| Mar 2017 | - | $1.13 M(-9.0%) |
| Dec 2016 | $1.24 M(+2.3%) | $1.24 M(+40.2%) |
| Sep 2016 | - | $883.30 K(-11.0%) |
| Jun 2016 | - | $992.60 K(-9.9%) |
| Mar 2016 | - | $1.10 M(-9.0%) |
| Dec 2015 | $1.21 M(+3.0%) | $1.21 M(-5.4%) |
| Sep 2015 | - | $1.28 M(+33.2%) |
| Jun 2015 | - | $961.50 K(-10.0%) |
| Mar 2015 | - | $1.07 M(-9.1%) |
| Dec 2014 | $1.18 M(-76.7%) | $1.18 M(-5.3%) |
| Sep 2014 | - | $1.24 M(+52.1%) |
| Jun 2014 | - | $815.80 K(-75.5%) |
| Mar 2014 | - | $3.34 M(-33.8%) |
| Dec 2013 | $5.04 M(-81.2%) | $5.04 M(-64.9%) |
| Sep 2013 | - | $14.38 M(-46.3%) |
| Dec 2012 | $26.77 M(>+9900.0%) | $26.77 M |
| Dec 2011 | $0.00 | - |
FAQ
- What is Aldeyra Therapeutics annual total long term liabilities?
- What is the all time high annual total long term liabilities for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics annual total long term liabilities year-on-year change?
- What is Aldeyra Therapeutics quarterly total long term liabilities?
- What is the all time high quarterly long term liabilities for Aldeyra Therapeutics?
- What is Aldeyra Therapeutics quarterly long term liabilities year-on-year change?
What is Aldeyra Therapeutics annual total long term liabilities?
The current annual total long term liabilities of ALDX is $6.27 M
What is the all time high annual total long term liabilities for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high annual total long term liabilities is $26.77 M
What is Aldeyra Therapeutics annual total long term liabilities year-on-year change?
Over the past year, ALDX annual total long term liabilities has changed by -$8.65 M (-57.97%)
What is Aldeyra Therapeutics quarterly total long term liabilities?
The current quarterly long term liabilities of ALDX is $15.07 M
What is the all time high quarterly long term liabilities for Aldeyra Therapeutics?
Aldeyra Therapeutics all-time high quarterly total long term liabilities is $26.77 M
What is Aldeyra Therapeutics quarterly long term liabilities year-on-year change?
Over the past year, ALDX quarterly total long term liabilities has changed by +$12.41 M (+467.15%)